View in EDS HTML Full Text PDF Full Text

Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.

Saved in:
Bibliographic Details
Title: Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.
Authors: Lanamtieng T; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland. theerin.lanamtieng@helsinki.fi., Mervaala-Muroke A; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland., Toivanen L; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland., Porkka K; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland.; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; ICAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Brück O; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland. oscar.bruck@hus.fi.
Source: Annals of hematology [Ann Hematol] 2026 Feb 06; Vol. 105 (3), pp. 94. Date of Electronic Publication: 2026 Feb 06.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41649561
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lanamtieng+T%22">Lanamtieng T</searchLink>; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland. theerin.lanamtieng@helsinki.fi.<br /><searchLink fieldCode="AU" term="%22Mervaala-Muroke+A%22">Mervaala-Muroke A</searchLink>; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland.<br /><searchLink fieldCode="AU" term="%22Toivanen+L%22">Toivanen L</searchLink>; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland.<br /><searchLink fieldCode="AU" term="%22Porkka+K%22">Porkka K</searchLink>; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland.; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; ICAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Brück+O%22">Brück O</searchLink>; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland. oscar.bruck@hus.fi.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2026 Feb 06; Vol. 105 (3), pp. 94. <i>Date of Electronic Publication: </i>2026 Feb 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41649561
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00277-026-06863-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 94
    Titles:
      – TitleFull: Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lanamtieng T
      – PersonEntity:
          Name:
            NameFull: Mervaala-Muroke A
      – PersonEntity:
          Name:
            NameFull: Toivanen L
      – PersonEntity:
          Name:
            NameFull: Porkka K
      – PersonEntity:
          Name:
            NameFull: Brück O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 02
              Text: 2026 Feb 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0584
          Numbering:
            – Type: volume
              Value: 105
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Annals of hematology
              Type: main
ResultId 1